We may earn a commission from provider links, at no added cost to you. Compensation never changes scores; some lists place partners first. Read our affiliate disclosure.
Omzo review
Cost a year out and the banner stops helping. A first month of $199 plus eleven at $299 is $3,488 for semaglutide; the "$179" on the front page never appears on a bill. Tirzepatide is $349 then $399, so $4,738. The prices are real and itemized — they are just in the Terms and Conditions rather than on a pricing page, and the tirzepatide figure the homepage advertises is not in that schedule at all.
then $299/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Omzo at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- All 50 states
- Start
- Days after the telehealth consultation
How we scored Omzo
Each factor is read off Omzo's published pricing, disclosures and intake flow, and the six roll up into the 49/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Tiered or opaque — the true monthly is hard to pin down up front.
Broad coverage, but not a confirmed all-50 footprint.
Not a two-molecule plan on the published facts — switching may mean starting again elsewhere.
Exit terms are the weak point: lock-in, notice periods, or a cancellation path that isn't published.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
The weakest showing on speed — a slow published timeline, or none at all.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- omzo.com
Checked on 18 August 2026, with the figures taken from the Terms and Conditions, the only surface carrying a schedule. Compounded semaglutide is $299 a month after $199 for the first; tirzepatide $399 after $349. Costed out, that is $3,488 for a first year of semaglutide and $4,738 for tirzepatide. Brand-name Ozempic and Zepbound are $1,299 and $1,399 a month, first month and after, each covering consultation, prescription, medication and shipping. Three things about the advertising. The homepage's "starting at $179" is 40% below the ongoing rate. The Terms describe $179 as the original price and $199 as the current one, which is an increase written as a markdown. And "$279", the homepage's tirzepatide figure, appears nowhere in the schedule. In its favor, the same document is more explicit about compounding than most: compounded drugs are not FDA-approved, the agency does not review them for safety or quality, and no equivalence to an approved drug is claimed. It serves all 50 states, carries a LegitScript seal, names no operating company or compounding pharmacy, and screened clean against the live FDA warning-letter index.
What to expect when you sign up
We walked Omzo's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on omzo.com (https://www.omzo.com/quiz-v2)
- 2The signup page opened normally when we checked it on 2026-08-21
- 3We stopped at the first signup screen and entered no personal details, so we can't tell you what comes after it
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideFollow-up months — the standing rateThe Terms publish "Follow-Up Consultation - GLP-1 ... Priced at $299", with the first month at $199. The homepage advertises "Starting at $179" — a figure the Terms describe as the ORIGINAL price, now superseded by a higher one. | $199 → $299 | Follow-up months — the standing rateThe Terms publish "Follow-Up Consultation - GLP-1 ... Priced at $299", with the first month at $199. The homepage advertises "Starting at $179" — a figure the Terms describe as the ORIGINAL price, now superseded by a higher one. |
| Compounded tirzepatideFollow-up months — the standing rate"Follow-Up Consultation - GLP-1 + GIP ... Priced at $399", first month $349. The homepage's "Starting at $279" appears nowhere in the schedule at all. | $349 → $399 | Follow-up months — the standing rate"Follow-Up Consultation - GLP-1 + GIP ... Priced at $399", first month $349. The homepage's "Starting at $279" appears nowhere in the schedule at all. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Omzo's public disclosures at last review and change often; confirm the current number on Omzo's own site.
What we like
- Six packages, each with a first-month and an ongoing price, all published
- Consultation, prescription, medication, shipping and ongoing support are named as included in each
- Explicit about compounding: not FDA-approved, not reviewed for safety or quality, no equivalence claimed
- Brand-name Ozempic and Zepbound are priced, at $1,299 and $1,399 a month
- All 50 states, and it says it ships nowhere outside them
- LegitScript certified
The caveats
- The advertised $179 is 40% below the $299 that applies from month two
- "Originally priced at $179, currently offered at $199" is an increase written as a markdown
- $279, the homepage's tirzepatide figure, is not in the schedule in any position
- The schedule lives in a legal page that nothing on the site links to
- No operating company named anywhere in the legal pages
- No compounding pharmacy named
Omzo for working moms: our verdict
Omzo is best assessed on the total charge, your state eligibility, and how easily you can stop future billing. The advertised entry is $199, but the standing rate settles near $299/month — so read the headline as a starting offer, not the monthly line on your budget.
Before choosing Omzo, confirm the prescription offered, the services included, and the renewal terms. The sections below separate those decisions so you can compare the same costs and commitments.
What Omzo will cost you
- Compounded semaglutide — Follow-up months — the standing rate: $199 to start, then $299/mo
- Compounded tirzepatide — Follow-up months — the standing rate: $349 to start, then $399/mo
- Brand-name semaglutide — Ozempic — every month: $1299/mo
- Brand-name tirzepatide — Zepbound — every month: $1399/mo
For context, the typical ongoing price across our roster is around $179/month, so Omzo sits at the premium end.
The medications Omzo prescribes
Omzo prescribes semaglutide and tirzepatide. Availability of both does not guarantee that switching is appropriate or that a new evaluation is unnecessary. The provider record lists access to FDA-approved brand products; confirm the exact medication and coverage with the clinician.
Where Omzo fits — and where it doesn't — for working moms
Right for you if…
- nationwide access matters — a move for work or family shouldn't interrupt care.
Not your best option if…
- you have to run it through insurance — this is cash-pay, as most of the market is.
Trust, safety, and the fine print
Before enrolling with Omzo, confirm the clinician, the dispensing pharmacy, and how to reach the care team between refills. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
Discuss pregnancy plans and breastfeeding with your clinician before starting or continuing treatment. Product-specific recommendations differ; this program review cannot establish that a medication is appropriate for you.
The bottom line
Choose Omzo only when the ongoing cost and care arrangements fit your needs. Ask for the next charge, the cancellation deadline, and a contact for treatment questions before paying. Compare the same drug, supply period, and commitment across providers.
The bottom line for working moms
Best for: A mother budgeting twelve months who wants a published schedule, even if she has to open a legal page to find it.
Alternatives to Omzo
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete review directory.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- Visit Gala HealthRx-Readiness85100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included partner if you can live with a yearly plan and a pharmacy it doesn't name.
Keep comparing Omzo
Head-to-head & alternatives
Omzo, answered
- How much does Omzo cost?
- Budget around $299/mo — that was Omzo's lowest ongoing compounded rate at last review ($299/mo semaglutide, $399/mo tirzepatide). Verify the all-in figure on their site before you plan around it; these numbers change often.
- Can I start Omzo without a scheduled video visit?
- Confirm the consultation format directly with Omzo. An online program may still require a live visit depending on your state, clinician and medical needs; the score alone does not establish your intake requirements.
- Does Omzo offer both semaglutide and tirzepatide?
- Omzo lists tirzepatide access as well as semaglutide. Confirm the exact treatment offered to you; switching requires clinician approval and may involve a new evaluation or different cost.
- Where does Omzo rank for working moms?
- Omzo earns 49/100 on our Rx-Readiness Score, ranking #256. Speed to first dose and flat pricing carry the most weight of the six factors behind it. Compare the price, care arrangements and eligibility described in the review.
Pricing, states and verification reflect Omzo's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.